Key Takeaways
- • Sheridan Capital Partners closed $1.345 billion across two new funds, advised by Kirkland & Ellis LLP, marking a significant capital raise for the healthcare-focused investment platform.
- • The newly raised capital will be deployed across multiple healthcare sectors, positioning Sheridan for active deal-making in the healthcare investment space.
- • The fundraise reflects continued institutional confidence in Sheridan's healthcare investment strategy and Kirkland's role as a key legal advisor in alternative asset management.
Summary
Sheridan Capital Partners announced on October 7, 2026, that it successfully closed $1.345 billion in capital commitments across two newly launched funds. The firm, advised by leading law firm Kirkland & Ellis LLP, disclosed the fundraise as it positions itself for investment activity across diverse healthcare sectors. The scale of the raise underscores sustained investor demand for healthcare-focused alternative investment vehicles, particularly as healthcare remains a dynamic area for private capital deployment.
The two-fund structure allows Sheridan to segment its investment strategy while maintaining a unified capital base, a common approach among sector-specialists managing multiple investment mandates simultaneously. The healthcare sector continues to attract significant private capital due to persistent secular tailwinds, including aging demographics, technological innovation in medical devices and pharmaceuticals, and consolidation opportunities within fragmented healthcare services markets.
Kirkland & Ellis's involvement as legal counsel reflects the firm's prominent role advising alternative asset managers on fund formation and capital raises. The $1.345 billion haul positions Sheridan as an active participant in healthcare investing, with the capital ready for deployment into transactions across the healthcare landscape.
The two-fund structure allows Sheridan to segment its investment strategy while maintaining a unified capital base, a common approach among sector-specialists managing multiple investment mandates simultaneously. The healthcare sector continues to attract significant private capital due to persistent secular tailwinds, including aging demographics, technological innovation in medical devices and pharmaceuticals, and consolidation opportunities within fragmented healthcare services markets.
Kirkland & Ellis's involvement as legal counsel reflects the firm's prominent role advising alternative asset managers on fund formation and capital raises. The $1.345 billion haul positions Sheridan as an active participant in healthcare investing, with the capital ready for deployment into transactions across the healthcare landscape.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.